2-(2-methoxyethoxy)ethyl methacrylate

Names

[ Name ]:
2-(2-methoxyethoxy)ethyl methacrylate

[Synonym ]:
Diethylene Glycol MonoMethyl Ether Methacrylate
EINECS 256-190-2
2-(2-Methoxyethoxy)ethyl Methacrylate
Methacrylic Acid 2-(2-Methoxyethoxy)ethyl Ester
Methyl Carbitol Methacrylate
MFCD00059330

Chemical & Physical Properties

[ Density]:
1.02 g/mL at 25ºC(lit.)

[ Boiling Point ]:
98ºC3.5 mm Hg(lit.)

[ Molecular Formula ]:
C₉H₁₆O₄

[ Molecular Weight ]:
188.22100

[ Flash Point ]:
>230 °F

[ Exact Mass ]:
188.10500

[ PSA ]:
44.76000

[ LogP ]:
0.76870

[ Index of Refraction ]:
n20/D 1.44(lit.)

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H317-H319-H335

[ Precautionary Statements ]:
P261-P280-P305 + P351 + P338

[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ Hazard Codes ]:
Xi

[ Risk Phrases ]:
36/37/38-43

[ Safety Phrases ]:
26-36/37

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2916140000

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

Customs

[ HS Code ]: 2916140000

[ Summary ]:
2916140000. other esters of methacrylic acid. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:80.0%

Articles

Hydrophilicity/Hydrophobicity reversable and redox-sensitive nanogels for anticancer drug delivery.

Mol. Pharm. 12 , 1636-47, (2015)

Long circulation in the blood, efficient cellular internalization, and intracellular drug release in the tumor cells are major challenges in the development of ideal anticancer drug delivery systems. ...

Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers.

ACS Nano 9 , 11023-33, (2015)

A new ultrasound-responsive system based on mesoporous silica nanoparticles was developed for biomedical applications, grafting a copolymer on their surface that acts as gatekeeper of the pores. The n...

"Triple-punch" strategy for triple negative breast cancer therapy with minimized drug dosage and improved antitumor efficacy.

ACS Nano 9(2) , 1367-78, (2015)

Effective therapeutics against triple negative breast cancer (TNBC), which has no standard-of-care therapy, needs to be developed urgently. Here we demonstrated a strategy of integrating indocyanine g...